AtaGenix Laboratories

Home - About Us - Updates Center - News

International Life Sciences Leaders Visit AtaGenix: Advancing Antibody R&D with Velocity and Rigor

Release time: 2025-10-15   View volume: 83

AtaGenix, a premier innovator in antibody discovery and development, hosted a distinguished delegation of international life sciences leaders at our state-of-the-art facilities in Wuhan, China. The visit featured representatives from Pivotal Scientific Limited, 2BScientific Ltd., ARP American Research Products, Inc., and GeneTex, Inc. This collaborative event provided an immersive deep-dive into AtaGenix's cutting-edge integrated antibody discovery and development platform.

Representatives from global life sciences companies explore AtaGenix's advanced R&D laboratories in Wuhan.

Representatives from global life sciences companies explore AtaGenix's advanced R&D laboratories in Wuhan.

At the core of our platform is a sophisticated design–build–test–learn engine that accelerates programs from antigen design to IND-enabling assets with decision-gated transparency, ensuring unparalleled speed, precision, and efficiency for global partners. This comprehensive workflow, detailed in the diagram below, showcases our multi-channel antibody discovery and validation process.

AtaGenix Workflow Diagram

AtaGenix’s integrated workflow for robust protein production, multi-channel antibody discovery, and validation.

This gathering underscores AtaGenix's commitment to fostering international collaborations, bridging our technological expertise with the global networks of these esteemed organizations to drive innovation in antibody solutions worldwide.

Platform Highlights

Our end-to-end platform integrates proprietary technologies across the antibody development pipeline, yielding high-quality candidates with expedited timelines and embedded developability evaluations. Key components include:

  • Robust Protein Production Platform: Utilizes AI-driven target gene design and cloning strategies, supported by our experienced engineers. Offers versatile expression systems including E. coli, mammalian, yeast, insect, and Bacillus subtilis, ensuring optimal protein yields for downstream applications.
  • Multi-Channel Antibody Discovery: Features multiple pathways such as hybridoma generation (mouse/rat), phage-displayed antibody libraries with biopanning (3-5 cycles), and the innovative Xten™ Mab Single B Cell Sorting for single-cell RT-PCR and sequencing. This multi-faceted approach maximizes diversity and specificity.
  • Antibody Validation: Employs advanced techniques like WB/IP/Co-IP, IF/IHC, FACS, ELISA, and open SPR to rigorously validate antibody sequences, transient expression, stable cell lines, and functional activity, ensuring robust performance.

Showcasing AtaGenix's innovative antibody development technologies during the visit.

Showcasing AtaGenix's innovative antibody development technologies during the visit.

"Hosting these global leaders reinforces AtaGenix's position at the forefront of antibody R&D. By sharing our platform's capabilities, we aim to catalyze new partnerships that accelerate breakthroughs in biologics worldwide." — Qin Fubo, Founder of AtaGenix

Looking Ahead: Expanding Global Collaborations

AtaGenix and its strategic subsidiary abinScience are excited to extend their capabilities to the international networks of Pivotal Scientific Limited, 2BScientific Ltd., ARP American Research Products, Inc., and GeneTex, Inc. The visit included key representatives such as Tim Bernard from Pivotal Scientific Limited, Will Kaye from 2BScientific Ltd., Dan Souw from ARP American Research Products, Inc., and Jonas Baeuerle from GeneTex, Inc. AtaGenix will lead the charge in providing advanced technical services, leveraging our cutting-edge platform for collaborative R&D programs. Meanwhile, abinScience will focus on product sales, offering premium life science reagents to meet global demand. Through technical exchanges, co-marketing initiatives, and streamlined engagement, this partnership ensures rapid advancement and scientific excellence in novel biologics and pipeline optimization.

AtaGenix teams engage with international visitors on future partnership opportunities.

From gene to antibody—We Make It Happen. Watch for forthcoming webinars and case studies highlighting these synergies.

For inquiries or partnership discussions, reach us at info@atagenix.com.

About abinScience

abinScience, a strategic subsidiary of AtaGenix founded in 2023, leverages its parent company's global leadership in antibody and protein research, with over 14 years of experience since 2011. Inheriting advanced technologies and high-quality standards, abinScience focuses on premium life science reagents. Notably, the proprietary XtenCHO™ system, offering transient and stable expression modes, is recognized as a pivotal technology for enhancing protein production efficiency, solidifying abinScience's foundation in product development and aligning with the robust protein production platform showcased in our workflow.

About the Visiting Companies

Pivotal Scientific Limited

Founded in 2008 and headquartered in Kirtlington, United Kingdom, Pivotal Scientific is an international biotechnology consultancy dedicated to guiding life science companies through strategic growth, from inception to successful exit. With over 15 years of experience, the firm has served more than 100 biotech companies worldwide, offering tailored services in areas such as market expansion, mergers and acquisitions (M&A), B2B introductions, marketing, and consultancy. Pivotal Scientific's global network and in-depth industry knowledge make it a trusted partner for small-to-medium-sized enterprises (SMEs) in the research reagent and life sciences sectors, helping them enhance sales, brand awareness, and overall business development.

2BScientific Ltd.

Established in 2009 and based in Oxfordshire, UK, 2BScientific Ltd. is a leading distributor of innovative life science products, serving researchers in the UK, Europe, and beyond. The company is reinventing the supply chain for life science reagents and kits, focusing on efficiency and accessibility in the European research market.

ARP American Research Products, Inc.

Founded in 1994 in Massachusetts, USA, ARP American Research Products, Inc. has been supplying high-quality research and diagnostic products to laboratories, hospitals, universities, and biotech firms globally for over 30 years. ARP's mission centers on empowering scientific breakthroughs through reliable lab research products.

GeneTex, Inc.

GeneTex, Inc., established in 1997 in San Antonio, Texas, USA, specializes in essential biomedical reagents including antibodies, proteins, and research kits. Founded by renowned scientists in oncology, cancer biology, and infectious diseases, the company accelerates life science research worldwide.

Messages